Uromodulin as a biomarker for lupus nephritis
This study looks at whether a protein called uromodulin in the blood can help doctors tell how lupus nephritis (kidney inflammation caused by lupus) is affecting the kidneys. It compares uromodulin levels in people with lupus nephritis, people with lupus but no kidney problems, people with other kidney diseases, and healthy people.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with lupus (systemic lupus erythematosus).
- You may have kidney problems from lupus (lupus nephritis) that have been confirmed by a kidney biopsy.
- You may have lupus without kidney involvement, or you may have a different type of kidney disease (not caused by lupus).
- You are not pregnant or breastfeeding.
- You do not have end-stage kidney disease requiring dialysis, a history of kidney transplant, active infection, active cancer, heart failure, or diabetes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study measures a blood protein called IL-33 in people with lupus, including those with kidney involvement (lupus nephritis), to see if it relates to their symptoms. It may help doctors understand lupus better and find new ways to treat it.
This study aims to find better ways to detect kidney problems in people with lupus by testing blood and urine samples. If you have lupus, you may help researchers improve how kidney disease is diagnosed and monitored.
This study looks at blood and urine markers that may show how active lupus kidney disease is and how it changes over time. It may help doctors better monitor people with active lupus-related kidney inflammation.
This study looks at a simple urine test to see if it can show how active lupus nephritis (kidney inflammation caused by lupus) is. It might help doctors monitor the condition without needing repeated biopsies.
This study looks at whether a specific antibody (anti-alpha-actinin) in the blood is linked to active lupus kidney disease. It may help doctors better understand and monitor kidney problems in people with lupus.
This study is looking for biomarkers (clues in your blood, urine, or tissue) that can help predict how well lupus nephritis (kidney inflammation caused by lupus) responds to treatment. It focuses on people who have active kidney disease and are either starting treatment or have been on a stable treatment for at least a month.
Hear when a new Uromodulin trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.